Pediatric Pharmacy

PGY2-Pediatrics-2018-Image.jpg#asset:3215

The purpose of the University of Oklahoma Health Sciences Center Residency Training Program through OU Health Oklahoma Children’s Hospital PGY2 Pediatric Residency is to build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in advanced or specialized practice. This PGY2 residency provides residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care that improves medication therapy. Residents who successfully complete this accredited PGY2 Pediatric Pharmacy Residency should possess competencies that qualify them for a clinical pharmacist and/or faculty position and prepare them to be eligible for attainment of Board of Pharmacy Specialties (BPS) Board Certification in Pediatric Pharmacy (BCPPS). 



Description

This one-year position provides the resident with the academic rank of Clinical Instructor with the University of Oklahoma College of Pharmacy (OUCOP). The residents are primarily involved in clinical practice at Oklahoma Children’s Hospital at OU Health. Educational responsibilities and training include didactic (lecture) and experiential (rotation) teaching to Pharm.D. students in addition to other activities. The PGY2 Pediatric Pharmacy resident is expected to complete the Advanced Teaching Skills for Residents teaching certificate program, which requires teaching activities in the clinical arena, the classroom, and the laboratory setting. In addition, the resident will be required to complete an original research project for completion of the residency program; they will be expected to present their research at national meetings and will be encouraged to publish their findings.  



Outcomes

The University of Oklahoma Health Sciences Center Residency Training Program through OU Health Oklahoma Children’s Hospital PGY2 Pediatric residents are expected to achieve 80% of these educational outcomes for the residency. The remaining 20% must be assessed at a minimum of satisfactory progress. These include the objectives under the five required competency areas (R1—patient care, R2—advancing practice and improving patient care, R3—leadership and management, R4—teaching/education/dissemination of knowledge, R5—management of medical emergencies) as well as the objectives under two of the elective competency areas (E1—academia and E4—added skills for pediatric pharmacy scholarship). 

In addition to this, residents are also expected to document coverage of the required pediatric disease states listed at the end of the ASHP Educational Outcomes, Goals, and Objectives for PGY2 Pediatric Pharmacy residents. By the end of the program, residents are expected to complete 90% of the required disease topics. 



Practice Site

The Downtown Campus of OU Health in Oklahoma City is comprised of two hospitals: Oklahoma Children’s Hospital at OU Health and University of Oklahoma Medical Center. Oklahoma Children’s Hospital at OU Health is a 314-bed teaching hospital with a 93-bed Neonatal ICU, a 34-bed Medical ICU, and a 24-bed Cardiovascular ICU (CICU). It is the only comprehensive children's hospital in the state of Oklahoma.   



Residency Rotations

  • Month-Long Rotations

    • Orientation (if applicable)—1 month
    • General Pediatrics 1—1 month
    • General Pediatrics 2 (Required precepting month for APPE students)—1 month
    • PICU—1 month
    • Neonatal ICU—2 months
    • Pediatric Hematology/Oncology—1 month
    • Pediatric Nephrology—1 month
    • CICU—1 month
    • Research—1 month
    • Electives—2-3 months*

    *Various options exist for electives based on the resident’s interest. Residents may complete additional rotations in similar areas or seek new experiences in areas of interest. These opportunities include Solid Organ Transplant, Toxicology/Poison Control, Pediatric Stem Cell Transplant, and Other (depending upon the resident’s interest and preceptor availability).

  • Longitudinal Rotations

    • Research Longitudinal Rotation (July-June)
    • Longitudinal Teaching Rotation (July-June)**
    • Longitudinal Ambulatory Care Rotation (1 half-day per week, July-June)
    • Pharmacy Practice and Management (July-June)
    • Longitudinal Staffing Rotation (July-June)

    **All PGY2 residents are expected to complete the Advanced Teaching Skills for Residents teaching certificate program. 


Other Requirements and Opportunities

  • Teaching

    The resident delivers at a minimum of two lectures to Pharm.D. students throughout the year. Residents also assist with small group facilitation, lab work, and course coordination. Teaching also occurs throughout the year as the resident presents interdisciplinary in-services to the medical and nursing staff and assists with precepting of Pharm.D. students in the experiential portion of their curriculum. The resident assumes primary precepting responsibility for P4 students during the latter part of the residency.

  • Research

    Residents complete a research curriculum which includes the University of Oklahoma Health Sciences Center Institutional Review Board (IRB) certification for conducting human research and specific research training sessions through Resident Rounds. Each resident designs and executes an original research project under the mentorship of their research committee, which consists of the residency program director, an expert in the practice area in which research will be conducted, and an expert in study design, data analysis, and statistical methods. Residents present preliminary research findings during a podium presentation at the Pediatric Pharmacy Association Annual Meeting and the Oklahoma Pharmacy Residency Conference. In accordance with ASHP standards, residents prepare a high-quality manuscript based on their research findings.

  • Scholarship

    The resident participates in the peer-review of at least two manuscripts submitted for publication. The resident is also expected to contribute to the literature through preparation and publication of a newsletter article, a case report or review article, and their original research.

  • Pharmacy Practice Management

    The resident develops practice management skills through participation in institutional projects and committee work at The Oklahoma Children’s Hospital at OU Health. In addition, the resident develops their leadership philosophy through readings and discussions with the leadership preceptor and one-on-one meetings with local pharmacy leaders.

  • Professional Service

    Professional Organization Involvement

    Resident involvement in local and national professional organizations (as their residency schedule allows) is encouraged. Examples include:

    • Oklahoma Society of Health-System Pharmacists (OSHP)
    • American Society of Health-System Pharmacists (ASHP)
    • American College of Clinical Pharmacy (ACCP)
    • American Association of Colleges of Pharmacy (AACP)
    • Pediatric Pharmacy Association (PPA)

    University of Oklahoma College of Pharmacy Committees 

    Resident involvement in college committees is also encouraged. Examples include:

    • One academic committee to support the College
    • OUCOP department meetings
    • Other meetings based on resident interests


Residency Program Director

Peter N. Johnson, Pharm.D., BCPS, BCPPS, FPPA, FCCM, FASHP

Professor, Department of Pharmacy: Clinical and Administrative Sciences. Practice area: CICU, PICU (back-up coverage), and inpatient general pediatrics



Residency Program Preceptors

Molly Adams, Pharm.D., BCPS  OB Clinical Pharmacist, Oklahoma Children’s Hospital at OU Health.  Practice area:  OB/GYN and longitudinal staffing preceptor.

Jennifer Dannelley, Pharm.D. Pediatric Clinical Pharmacist, Oklahoma Children’s Hospital at OU Health. Practice area: Cystic fibrosis, pulmonology.

Kristie Edelen, Pharm.D., DABAT.  Senior Specialist in Poison Information, Oklahoma Center for Poison and Drug Information. Practice area: Toxicology/poison control.

Maura Harkin, Pharm.D..  Pediatric Clinical Pharmacist, Oklahoma Children’s Hospital at OU Health. Practice area: PICU and CICU (back-up coverage). 

Teresa V. Lewis, Pharm.D., BCPS. Associate Professor, Department of Pharmacy: Clinical and Administrative Sciences. Practice area: Pediatric nephrology, pediatric renal transplant, and inpatient general pediatrics.

Jamie Miller, Pharm.D., BCPS, BCPPS, FPPA. Associate Professor, Department of Pharmacy: Clinical and Administrative Sciences. Practice area: Neonatology, and inpatient general pediatrics. 

Phu Nguyen, Pharm.D. Clinical Pharmacy Specialist in Solid Organ Transplant, Oklahoma Children’s Hospital at OU Health. Practice area: Adult and pediatric liver, kidney, and pancreas transplant.

Whitney Pittman, Pharm.D. Pediatric Clinical Pharmacist, Oklahoma Children’s Hospital at OU Health. Practice area: Hematology and oncology and stem cell transplant.

Katy Stephens, Pharm.D.  Pediatric Clinical Pharmacist, Oklahoma Children’s Hospital at OU Health.  Practice area:  Neonatology.

Dyan Fleming, Pharm.D., BCPS, BCPPS. Clinical Pharmacy Manager—Pediatrics, Oklahoma Children’s Hospital at OU Health. Practice area: Pharmacy practice management.




Current Residents

Caitlyn Bradford, Pharm.D. (2021-2022); PGY1—University of Oklahoma College of Pharmacy; Oklahoma City, OK and Doctor of Pharmacy—University of Kentucky College of Pharmacy; Lexington, KY. 

Research project:  Delirium treatment strategies in critically ill pediatric patients:  a multi-site survey project



Residency Program Alumni

Katy Stephens, Pharm.D. (2020-2021).  Pediatric Clinical Pharmacy Specialist—NICU, Oklahoma Children’s Hospital at OU Health; Oklahoma City, OK.

Khalid Taher, Pharm.D. (2020-2021). Pediatric Clinical Pharmacy Specialist—PICU and Emergency Medicine, King Faisal Specialist Hospital, Riyadh, Saudi Arabia.

Maura Harkin, Pharm.D. (2019-2020).  Pediatric Clinical Pharmacy Specialist—PICU, Oklahoma Children’s Hospital at OU Health; Oklahoma City, OK.

Brittany Powers Shaddix, Pharm.D., BCPPS (2018-2019).  Clinical Pharmacy Specialist—Neonatology, Studer Family Children’s Hospital at Ascension Sacred Heart; Pensacola, FL. 

Amy Nguyen, Pharm.D. (2016-2017), BCPPS. Pediatric Clinical Pharmacy Specialist and PGY1 Pharmacy Residency Program Director, Phoenix Children's Hospital; Phoenix, AZ.

Amanda Capino, Pharm.D., BCPPS (2015-2016). Clinical Assistant Professor, University of Mississippi School of Pharmacy; Jackson, MS. 

Katlyn (Katie) Hughes, Pharm.D., BCPPS (2014-2015). Clinical Pharmacy Specialist—Pediatric Medical ICU, Riley Children’s Hospital at Indiana University Health; Indianapolis, IN.  

Bethany Ibach, Pharm.D., BCPPS (2013-2014).

Megan Andrews Carroll, Pharm.D. (2012-2013).

Erin (Lammers) Martin, Pharm.D., BCPS, BCPPS (2011-2012), Pediatric Clinical Specialist, Missouri Health Care Women’s and Children’s Hospital; Columbia, MO.

Misty Miller, Pharm.D., BCPS, AAHIVP (2010-2011), Associate Professor, University of Oklahoma College of Pharmacy; Oklahoma City, OK.

Emily (Gish) Benefield, Pharm.D., BCPS, BCPPS (2009-2010), Advanced Clinical Pharmacist and PGY2 Pediatric Pharmacy Residency Program Director, Primary Children’s Medical Center; Salt Lake City, UT.

Brooke (Honey) Gildon, Pharm.D., BCPS, BCPPS, AE-C, FPPA (2008-2009), Professor, Southwestern University College of Pharmacy; Oklahoma City, OK.

Jamie Miller, Pharm.D., BCPS, BCPPS, FPPA (2007-2008), Professor and PGY1 Pharmacy Residency Program Director, University of Oklahoma College of Pharmacy; Oklahoma City, OK.

Teresa V. Lewis, Pharm.D., BCPS (2004-2005), Associate Professor, University of Oklahoma College of Pharmacy; Oklahoma City, OK.

Tracy Hagemann, Pharm.D., FCCP, FPPAG, Associate Dean and Professor, Clinical Pharmacy at the University of Tennessee College of Pharmacy; Nashville, TN.

Kelly Gabeau Martin, Pharm.D., Dallas, TX.

Chad Reynolds, Pharm.D., Vann Healthcare Pharmacy; Glasgow, KY.

Maria Santerio, Pharm.D., Clinical Pharmacist, Central Florida Medical Center; Tampa, FL.

Renee Bellinger, Pharm.D., Associate Professor, University of Incarnate Word; San Antonio, TX.

Bill Maish, Pharm.D.

Cathy Poon, Pharm.D., FPPA, Associate Provost for Interprofessional Education and Clinical Programs and Professor of Clinical Pharmacy at the University of the Sciences; Philadelphia, PA.



Accreditation

ASHP-Logo.gif#asset:3216

This residency program is accredited by the American Society of Health-System Pharmacists